KRAS and neoplasm: This study aimed to investigate the presence of KRAS mutations by ultra-sensitive droplet digital PCR in the resection and venous margins of R0 resected tumour samples, identifying rare microscopically undetectable tumour cells in tissue areas, declared healthy by the pathologist.